Estrogen receptor pathways to AP-1
- PMID: 11162939
- DOI: 10.1016/s0960-0760(00)00108-4
Estrogen receptor pathways to AP-1
Abstract
Estrogen receptor (ER) binds to estrogen response elements in target genes and recruits a coactivator complex of CBP-pl60 that mediates stimulation of transcription. ER also activates transcription at AP-1 sites that bind the Jun/Fos transcription factors, but not ER. We review the evidence regarding mechanisms whereby ER increases the activity of Jun/Fos and propose two pathways of ER action depending on the ER (alpha or beta) and on the ligand. We propose that estrogen-ERalpha complexes use their activation functions (AF-1 and AF-2) to bind to the p 160 component of the coactivator complex recruited by Jun/Fos and trigger the coactivator to a higher state of activity. We propose that selective estrogen receptor modulator (SERM) complexes with ERbeta and with truncated ERalpha derivatives use their DNA binding domain to titrate histone deacetylase (HDAC)-repressor complexes away from the Jun/Fos coactivator complex, thereby allowing unfettered activity of the coactivators. Finally, we consider the possible physiological significance of ER action at AP-1 sites.
Similar articles
-
Oestrogen receptor function at classical and alternative response elements.Novartis Found Symp. 2000;230:20-6; discussion 27-40. doi: 10.1002/0470870818.ch3. Novartis Found Symp. 2000. PMID: 10965500 Review.
-
Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.Chem Biol. 2001 May;8(5):427-36. doi: 10.1016/s1074-5521(01)00025-4. Chem Biol. 2001. PMID: 11358690
-
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.Mol Endocrinol. 1999 Oct;13(10):1672-85. doi: 10.1210/mend.13.10.0357. Mol Endocrinol. 1999. PMID: 10517669
-
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15161-6. doi: 10.1073/pnas.96.26.15161. Proc Natl Acad Sci U S A. 1999. PMID: 10611355 Free PMC article.
-
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. doi: 10.1016/s0960-0760(00)00104-7. J Steroid Biochem Mol Biol. 2000. PMID: 11162936 Review.
Cited by
-
Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.PLoS One. 2012;7(8):e44160. doi: 10.1371/journal.pone.0044160. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22952913 Free PMC article.
-
Membrane estrogen receptor regulation of hypothalamic function.Neuroendocrinology. 2012;96(2):103-10. doi: 10.1159/000338400. Epub 2012 Sep 14. Neuroendocrinology. 2012. PMID: 22538318 Free PMC article. Review.
-
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination.Mol Cancer Ther. 2024 Mar 4;23(3):285-300. doi: 10.1158/1535-7163.MCT-23-0351. Mol Cancer Ther. 2024. PMID: 38102750 Free PMC article.
-
Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.Mol Cell Endocrinol. 2007 Mar 15;267(1-2):106-15. doi: 10.1016/j.mce.2007.01.001. Epub 2007 Jan 16. Mol Cell Endocrinol. 2007. PMID: 17275994 Free PMC article.
-
Whole-genome cartography of estrogen receptor alpha binding sites.PLoS Genet. 2007 Jun;3(6):e87. doi: 10.1371/journal.pgen.0030087. Epub 2007 Apr 17. PLoS Genet. 2007. PMID: 17542648 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
